ANDA 215593, held by Civica. Ephedrine Sulfate.
As of Nov 16, 2026, ANDA 215593 (Ephedrine Sulfate), held by Civica, was first approved by FDA on Dec 23, 2025, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 23, 2025 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ephedrine Sulfate50MG/ML (50MG/ML) ยท solution;intravenous | Ephedrine Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters